SEDICO Pharmaceuticals Co.
Exhibitors
Information
1 / 1
SEDICO Pharmaceuticals: Pioneering Biopharma Innovation Since 1990
Established in 1989, SEDICO stands as one of Egypt's pioneering national biopharmaceutical companies in the MENA region. From launching high-quality biosimilars in 1990 to becoming the first Egyptian firm to produce insulin in 2002, we've evolved into a research-driven leader in advanced biotechnology. Our innovative programs deliver cutting-edge therapies for the world's most complex conditions, including oncology, with production lines spanning 180+ products across 14 therapeutic groups.
Foresight fueled our global expansion: In 1994, we launched the International Business Division to conquer international markets. Today, backed by world-class talent, state-of-the-art facilities, and strategic investments, SEDICO powers breakthroughs—operating a dedicated oncology facility with 30 products in production from a registered portfolio of 50.
Discover our latest advancements at WHX Dubai 2026.
